145 related articles for article (PubMed ID: 2183643)
21. Activated oncogenes in human tumors.
Suárez HG
Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
[TBL] [Abstract][Full Text] [Related]
22. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
23. [Oncogenes and anti-oncogenes in breast cancer].
Birnbaum D; Gaudray P
Bull Cancer; 1989; 76(7):677-87. PubMed ID: 2573395
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
[TBL] [Abstract][Full Text] [Related]
25. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
26. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
27. Gene activity associated with cancers treated by surgical oncologists.
Brackett DJ; Smith BJ; Lerner MR; Hanas JS; Postier RG
J Okla State Med Assoc; 2003 Oct; 96(10):485-94. PubMed ID: 14619604
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
29. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
[TBL] [Abstract][Full Text] [Related]
30. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
[TBL] [Abstract][Full Text] [Related]
31. [Significance of molecular genetics in oncology].
Parreira L
Acta Med Port; 1991 Dec; 4 Suppl 1():28S-34S. PubMed ID: 1805529
[TBL] [Abstract][Full Text] [Related]
32. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
33. The c-K-ras gene and human cancer (review).
Kahn S; Yamamoto F; Almoguera C; Winter E; Forrester K; Jordano J; Perucho M
Anticancer Res; 1987; 7(4A):639-52. PubMed ID: 3310850
[TBL] [Abstract][Full Text] [Related]
34. Oncogene analysis in diagnostic pathology. A current perspective.
Wick MR
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S1-3. PubMed ID: 1315487
[No Abstract] [Full Text] [Related]
35. Diagnostic immunohistochemistry: current applications and future directions.
Rahman S; Leong AS
Malays J Pathol; 1991 Jun; 13(1):17-28. PubMed ID: 1795557
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology primer for the pediatric pathologist.
Demetrick DJ
Pediatr Pathol; 1994; 14(2):339-67. PubMed ID: 8008694
[TBL] [Abstract][Full Text] [Related]
37. Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer.
Cordon-Cardo C; Sheinfeld J
World J Urol; 1997; 15(2):112-9. PubMed ID: 9144901
[TBL] [Abstract][Full Text] [Related]
38. Quantitative immunohistochemistry. Theoretical background and its application in biology and surgical pathology.
Fritz P; Multhaupt H; Hoenes J; Lutz D; Doerrer R; Schwarzmann P; Tuczek HV
Prog Histochem Cytochem; 1992; 24(3):1-53. PubMed ID: 1322548
[No Abstract] [Full Text] [Related]
39. Beyond hematoxylin and eosin--the role of immunohistochemistry in surgical pathology.
Jaffer S; Bleiweiss IJ
Cancer Invest; 2004; 22(3):445-65. PubMed ID: 15493365
[TBL] [Abstract][Full Text] [Related]
40. FISH in pathology.
Coyne JD
Int J Surg Pathol; 2012 Aug; 20(4):377. PubMed ID: 22614162
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
